Forty two Crohn's disease patients were followed up after ileocolic resection with regard to symptoms and endoscopic appearance of the ileocolic anastomosis. Twenty eight patients resected because of colonic neoplasm served as controls. In all the Crohn's disease patients the ileal resection margin was disease free macroscopically at operation. In addition, intraoperative ileoscopy was performed in 13 and no sign of residual inflammation in the neoterminal ileum was seen. Endoscopy soon after surgery often showed preanastomotic ileal ulceration before symptoms appeared, whereas no anastomotic lesions were observed in the controls. Thus, 22 of 30 Crohn's disease patients examined had ulceration of the anastomotic area after three months, but only 10 had developed symptoms indicating relapse (73 v 33%). Corresponding figures in the 30 patients examined after one year were 93 v 37%, and in 14 patients after three years they were 100 and 86% respectively. The inflammatory lesions in all cases were preanastomotic, in the neoterminal ileum, and showed time related progression from aphthae to larger ulcers and stricture. The study suggests that endoscopically observed inflammatory lesions that appear soon after ileocolic resection for Crohn's disease signify new inflammation and not residual, persistent disease or incomplete anastomotic healing. The data further suggest that despite clinical remission after apparently radical intestinal resection, the bowel is permanently inflamed in Crohn's disease.
Crohn's disease generally leads inevitably to severe intestinal inflammation and stricture. Resection of the diseased gut remains the standard option for the severely ill patient with defined segmental inflammation. Recurrence, however, is distressingly common, and it is now clearly established that surgery, even though apparently radical, offers no cure. The effect of surgery on the natural course of the disease is still controversial, and recurrence rates of 16-94% have been reported.'I" This difference is not surprising, as the diagnostic criteria for recurrence are highly variable, ranging from clinical manifestations through radiological or histological evidence of disease to need for surgical intervention.
Recurrent lesions after ileocaecal resection for ileal disease or colectomy with ileorectal anastomosis for colitis tend to be localised to the region of the anastomosis.4 1213 Morever, the overall postoperative recurrence rate was reported to be higher after colectomy and ileorectal anastomosis.9 '6 Colonoileoscopy provides unique opportunities for studying the early development of intestinal inflammation in this area. '7 In previous studies,'8 9 a recurrence rate of 72-73% was found within a year of operation, and after three years it was 87%.' Other authors202' have described endoscopic lesions in the ileocolic anastomosis within two to six months in 70% of their patients, and postulated that these early lesions are not true recurrences, but merely recrudescing foci not removed at the time of resection.
This study examined the endoscopic appearance of the anastomotic area and its relation to symptoms after ileocolic resection or colectomy for Crohn's disease. Because we wished to clarify whether lesions seen at endoscopy were true recurrences or simply non-resected, residual disease, only patients without grossly visible residual intraoperative inflammation were admitted to the study. In order to elucidate whether early anastomotic lesions represent changes specific for Crohn's disease, patients who had undergone ileocolic resection and anastomosis because of colonic neoplasm served as controls.
Patients and methods
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Results
Inflammatory lesions were visualised endoscopically in the region of the anastomosis in all 42 Crohn's disease patients but in no control subjects (p<O0Ol). The endoscopic findings and the symptoms in Crohn's disease patients three months and one, two, and three years after operation are summarised in Table I . Inflammatory lesions appeared regularly above the anastomosis in the neoterminal ileum, and in patients without concomitant colitis the lesions were strictly confined to the neoterminal ileum. In no case did the inflammation overbridge the mucosal join. In patients with concomitant colitis, the inflammation was more pronounced above than below the anastomosis, where the inflammation was a part of the colitis in the remaining colon. After three months, 73% of the patients examined had ileal inflammation above the anastomosis, but only 33% had developed symptoms indicating relapse. After one year the corresponding figures were 93% and 37%, and after two years they were 94% and 82%. All ofthe 14 patients examined after three years showed ileal inflammation above the anastomosis and all but two had developed clinical relapse (86%). Thirteen patients operated on during the same period, but not participating in the study, have been followed up with regard to symptoms. This group showed no difference (p>005) in the rate of symptomatic relapse after three months 38% (5/13), one year 62% (8/13), two years 62% (8/13), and three years 69% (9/13 . This is, however, the first study in which patients followed up after surgery were evaluated prospectively by a Crohn's disease activity index, and studies that do not use a formal activity index may underscore the symptoms. Our figures are more similar to those in other prospective studies in patients with apparently quiescent disease at entry, where a Crohn's disease activity index of more than 150 was considered to indicate relapse, a figure equivalent to the -4 Harvey-Bradshaw index in the present study.23 Relapse rates after one and two years were reported as 28 and 45%25 and 51 and 66%26 respectively in these studies, while we found rates of 37 and 82%.
In our patients the incidence of anastomotic inflammation three months after operation was similar to previous reports,2021 but at subsequent endoscopies it was higher than in earlier studies (93-100 v 72-79%). 181927 In early inflammation the lesions are often discrete and recognisable only to the trained eye. Our figures may reflect substantial experience in performing endoscopy in Crohn's disease patients, resulting in the larger number ofendoscopically detected lesions.
Our data do not support the view that recurrence of inflammation should be more common in Crohn's colitis than in ileal disease. In previous studies recurrence was commonly defined as a need for further resection' 2 7 1011 13 14 and the high rates reported may be explained by exacerbation of inflammation in the remaining Table I.   100   75   50   25 colon or rectum. Nor could we confirm previous data on higher recurrence rates after further resection than after primary resection."" Likewise, disease duration or a history of perforating disease had no influence on the postoperative evolution of inflammatory lesions. We were not able to visualise any anastomotic lesions in the patients resected because of colonic neoplasm, and in these patients we found complete healing of the anastomosis. They were followed up at a mean of six months, but some were seen after three months. All Crohn's disease patients retained their early ileal ulcers between three months and one year, and most showed progression. It is, thus, unlikely that early ulceration at the site of the anastomosis is a sign of incomplete healing or a reaction to sutures in the anastomosis, it probably represents lesions specific for Crohn's disease.
In the patients with Crohn's disease, recurrent anastomotic inflammation was always observed at the ileal side of the join, and in patients without concomitant colitis recurrent inflammation was confined to the neoterminal ileum. It is noteworthy that recurrence of inflammation above the anastomosis also developed in colitis patients without primary ileal involvement. Moreover, inflammation above the anastomosis was observed regardless of the operative procedure (ileocaecal resection, colectomy, or anastomotic resection). In addition, most patients followed showed progression to more severe ileal inflammation. These results, and the finding that the distal ileum is the prefered site for primary involvement in Crohn's disease,228 suggest that proximity to the colon may be harmful to the small intestine in this condition, and that colonic factors may contribute to small bowel inflammation. The low recurrence rate after colectomy with ileostomy,9'3 as well as previous findings that glucocorticoid treatment improves endoscopic colonic inflammation but not ileal inflammation above the anastomosis, as recently reported by us,29 underline the notion of inflammatory factors in the anastomotic area essentially affecting the distal ileum.
It has been suggested that inflammatory lesions found soon after intestinal resection represent residual inflammation not removed at surgery.2' Our series, however, comprised only patients in whom ileal resection had been performed in tissue free from macroscopic disease. In the last 13 patients intraoperative ileoscopy further confirmed the absence of inflammation in the neoterminal ileum anastomosed to the colon. We had no problem scrutinising the distal ileum at either intraoperative endoscopy or when inspecting the resection margin. Our high frequency of postoperative lesions indicates a high sensitivity in detecting minor lesions and may to some extent validate the intraoperative investigation -minor lesions were not easily overlooked. Our findings agree with two previous studies. In one the patients had their distal ileum everted and inspected at the time of resection, and after six months 21 of 22 developed ileal ulcerations. '19 In another, intraoperative ileoscopy was performed to confirm that 40 cm of the distal ileum was free from inflammatory lesions, and when followed 28 of 34 investigated patients had developed anastomotic lesions. 30 It is arguable that early ulceration could develop from residual microscopic ileal lesions. Although microscopy showed inflammation at the ileal resection margin in a few cases in our series, this did not seem to be an important factor, as early endoscopic lesions could develop independently of these findings (Table II) 
